Aslani, Iris .

HRN: 24-25-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
05/13/2024
05/20/2024
IV
27.5
OD
Pcap , T/c CNSInfectin
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: